DaShenLin Pharmaceutical Group Co., Ltd.SSE: 603233

(603233)"DaShenLin Pharmaceutical Group Co., Ltd."Report for Q3 2026

Oct 30, 2026 · Issued by DaShenLin Pharmaceutical Group Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Stock code 603233 · Oct 30, 2026

On 6ix: 6ix.com/news/603233dashenlin-pharmaceutical-group-co-ltdreport-for-q3-2026

Report for Q3 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix is reading this filing.

View original source (Shanghai Stock Exchange)DaShenLin Pharmaceutical Group Co., Ltd. on 6ix

Later from DaShenLin Pharmaceutical

(603233)"DaShenLin Pharmaceutical Group Co., Ltd."Announcement on Release of Pledge of Shares Held by the Controlling ShareholderNov 4

All DaShenLin Pharmaceutical news releases

Follow DaShenLin Pharmaceutical into a list and get an email when it puts out news.

Follow DaShenLin Pharmaceutical